- Home
- BRY vs PRME Comparison
BRY vs PRME Comparison
Compare BRY & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRY
- PRME
- Stock Information
- Founded
- BRY 1909
- PRME 2019
- Country
- BRY United States
- PRME United States
- Employees
- BRY N/A
- PRME N/A
- Industry
- BRY Oil & Gas Production
- PRME Medicinal Chemicals and Botanical Products
- Sector
- BRY Energy
- PRME Health Care
- Exchange
- BRY Nasdaq
- PRME Nasdaq
- Market Cap
- BRY 367.0M
- PRME 379.1M
- IPO Year
- BRY N/A
- PRME 2022
- Fundamental
- Price
- BRY $5.00
- PRME $2.89
- Analyst Decision
- BRY Hold
- PRME Strong Buy
- Analyst Count
- BRY 1
- PRME 9
- Target Price
- BRY $5.00
- PRME $13.13
- AVG Volume (30 Days)
- BRY 1.2M
- PRME 1.1M
- Earning Date
- BRY 03-05-2025
- PRME 02-28-2025
- Dividend Yield
- BRY 15.00%
- PRME N/A
- EPS Growth
- BRY 73.42
- PRME N/A
- EPS
- BRY 1.06
- PRME N/A
- Revenue
- BRY $806,733,000.00
- PRME $800,000.00
- Revenue This Year
- BRY N/A
- PRME N/A
- Revenue Next Year
- BRY N/A
- PRME $426.55
- P/E Ratio
- BRY $4.70
- PRME N/A
- Revenue Growth
- BRY N/A
- PRME N/A
- 52 Week Low
- BRY $3.72
- PRME $2.56
- 52 Week High
- BRY $8.88
- PRME $9.77
- Technical
- Relative Strength Index (RSI)
- BRY 73.47
- PRME 45.80
- Support Level
- BRY $4.68
- PRME $2.63
- Resistance Level
- BRY $5.09
- PRME $2.92
- Average True Range (ATR)
- BRY 0.20
- PRME 0.22
- MACD
- BRY 0.11
- PRME 0.00
- Stochastic Oscillator
- BRY 92.86
- PRME 27.08
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.